Literature DB >> 23047420

GDF-15 in heart failure: providing insight into end-organ dysfunction and its recovery?

Kai C Wollert, Tibor Kempf.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23047420     DOI: 10.1093/eurjhf/hfs158

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  4 in total

Review 1.  Progress in heart failure treatment in Germany.

Authors:  Mark Luedde; Martina E Spehlmann; Norbert Frey
Journal:  Clin Res Cardiol       Date:  2018-07-02       Impact factor: 5.460

2.  Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients.

Authors:  Christoph Sinning; Francisco Ojeda; Philipp S Wild; Renate B Schnabel; Michael Schwarzl; Sevenai Ohdah; Karl J Lackner; Norbert Pfeiffer; Matthias Michal; Maria Blettner; Thomas Munzel; Tibor Kempf; Kai C Wollert; Kari Kuulasmaa; Stefan Blankenberg; Veikko Salomaa; Dirk Westermann; Tanja Zeller
Journal:  Clin Res Cardiol       Date:  2016-12-21       Impact factor: 5.460

3.  Growth differentiation factor-15 (GDF-15), novel biomarker for assessing atrial fibrosis in patients with atrial fibrillation and rheumatic heart disease.

Authors:  Yong-Ming Zhou; Ming-Jiang Li; Yan-Li Zhou; Le-Le Ma; Xin Yi
Journal:  Int J Clin Exp Med       Date:  2015-11-15

4.  Chronic peripheral ghrelin injection exerts antifibrotic effects by increasing growth differentiation factor 15 in rat hearts with myocardial fibrosis induced by isoproterenol.

Authors:  Q Ren; P Lin; Q Wang; B Zhang; L Feng
Journal:  Physiol Res       Date:  2019-12-19       Impact factor: 1.881

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.